A Novel Electrochemical Microfluidic Chip Combined with Multiple Biomarkers for Early Diagnosis of Gastric Cancer

Nanoscale Research Letters

Volumn 10, Issue 1, 2015, Pages 1-9

  Xie, Yao ^a   Zhi, Xiao ^a,e   Su, Haichuan ^b   Wang, Kan ^a   Yan, Zhen ^c   He, Nongyue ^d   Zhang, Jingpu ^a   Chen, Di ^a   Cui, Daxiang ^a,e  

^a Shanghai Jiao Tong University   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d SOUTHEAST UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Early diagnosis; Electrochemical; Gastric cancer; Microfluidic chip; Multiple biomarkers

Indexed keywords

ANTIGENS; BIOMARKERS; CHEMICAL DETECTION; CONTAMINATION; DISEASES; FLUIDIC DEVICES; MICROFLUIDICS;

EARLY DIAGNOSIS; ELECTROCHEMICAL; GASTRIC CANCERS; MICROFLUIDIC CHIP; MULTIPLE BIOMARKERS;

DIAGNOSIS;

EID: 84949570181     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/s11671-015-1153-3     Document Type: Article

References (52)

1. WHO Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed February 2015.
2. Lordick F, Allum W, Carneiro F, Mitry E, Tabernero J, Tan P et al (2014) Unmet needs and challenges in gastric cancer: the way forward. Cancer Treat Rev 40(6):692–700
3. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
4. Cui DX, Zhang L, Yan XJ, Zhang LX, Xu JR, Guo Y et al (2005) A microarray-based gastric carcinoma prewarning system. World J Gastroentero 11(9):1273–1282
5. Wang K, Ruan J, Qian QR, Song H, Bao CC, Zhang XQ et al (2011) BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer. J Nanobiotecg 9:23
6. Ruan J, Song H, Qian QR, Li C, Wang K, Bao CC et al (2012) HER2 monoclonal antibody conjugated RNase-A-associated CdTe quantum dots for targeted imaging and therapy of gastric cancer. Biomaterials 33(29):7093–7102
7. Ma JB, Huang P, He M, Pan LY, Zhou ZJ, Peng LL et al (2012) Folic acid-conjugated LaF3:Yb, Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography. J Phys Chem B 116(48):14062–14070
8. Xu WC, Luo T, Li P, Zhou CQ, Cui DX, Pang B et al (2012) RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating alpha(v)beta(3) expression. Int J Nanomed 7:915–924
9. Huang P, Lin J, Wang XS, Wang Z, Zhang CL, He M et al (2012) Light-triggered theranostics based on photosensitizer-conjugated carbon dots for simultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 24(37):5104–5110
10. Huang P, Lin J, Wang SJ, Zhou ZJ, Li ZM, Wang Z et al (2013) Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials 34(19):4643–4654
11. Wang C, Bao C, Liang S, Zhang L, Fu H, Wang Y et al (2014) HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer. Nanoscale Res Lett 9(1):1–9
12. Liang S, Li C, Zhang C, Chen Y, Xu L, Bao C et al (2015) CD44v6 monoclonal antibody-conjugated gold nanostars for targeted photoacoustic imaging and plasmonic photothermal therapy of gastric cancer stem-like cells. Theranostics 5(9):970
13. Qi LF, Wu LX, Zheng S, Wang YL, Fu HL, Cui DX (2012) Cell-penetrating magnetic nanoparticles for highly efficient delivery and intracellular imaging of siRNA. Biomacromolecules 13(9):2723–2730
14. Zhang Y, Gao G, Liu H, Fu H, Fan J, Wang K et al (2014) Identification of volatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au-Ag alloy coated MWCNTs. Theranostics 4(2):154–162
15. Gui C, Wang K, Li C, Dai X, Cui DX (2014) A CCD-based reader combined with CdS quantum dot-labeled lateral flow strips for ultrasensitive quantitative detection of CagA. Nanoscale Res Lett 9:57
16. Mou X, Li T, Wang J, Ali Z, Zhang Y, Chen Z et al (2015) Genetic variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) genes and their correlation to gastric cancer risk based on universal tagged arrays and Fe3O4 magnetic nanoparticles. J Biomed Nanotechnol 11(11):2057–2066
17. Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma Y et al (2015) Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancer. Theranostics 5(7):733–745
18. Chen L, Bao CC, Yang H, Li D, Lei C, Wang T et al (2011) A prototype of giant magnetoimpedance-based biosensing system for targeted detection of gastric cancer cells. Biosens Bioelectron 26(7):3246–3253
19. Shu J, Li CG, Liu YC, Yan XC, Xu X, Huang XE et al (2012) Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. Asian Pac J Cancer P 13(5):2399–2403
20. Zhang J, Xu ZW, Yu LX, Chen ML, Li K (2014) Assessment of the potential diagnostic value of serum p53 antibody for cancer: a meta-analysis. PLoS One 9(6), e99255
21. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S (1993) p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54(5):759–764
22. Karim S (2009) Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroentero 15(11):1381–1387
23. Otani K, Li XX, Arakawa T, Chan FKL, Yu J (2013) Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn 13(5):445–455
24. Sisik A, Kaya M, Bas G, Basak F, Alimoglu O (2013) CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer P 14(7):4289–4294
25. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y (2014) Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17(1):26–33
26. Kwon OK, Yu W, Chung H (2013) Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer. Hepatogastroenterology 60(122):240–243
27. Fan BA, Xiong B (2011) Investigation of serum tumor markers in the diagnosis of gastric cancer. Hepatogastroenterology 58(105):239–245
28. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y et al (1998) Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 93(7):1090–1096
29. Boltin D, Gingold-Belfer R, Dickman R, Halpern M, Morgenstern S, Roth M et al (2014) Gastric mucin expression in first-degree relatives of gastric cancer patients. Eur J Gastroenterol Hepatol 26(7):710–714
30. Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J et al (2012) Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol 18(48):7357–7361
31. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA (1999) Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 44(5):693–697
32. Zhang XM, Li JX, Zhang GY, Li XH, Gu H (2014) The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterol 14:3
33. Malfertheiner P, Selgrad M, Bornschein J (2012) Helicobacter pylori: clinical management. Curr Opin Gastroen 28(6):608–614
34. Shafaghi A, Mansour-Ghanaei F, Joukar F, Sharafkhah M, Mesbah A, Askari K et al (2013) Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions. Asian Pac J Cancer P 14(6):3931–3936
35. Companioni O, Bonet C, Munoz X, Weiderpass E, Panico S, Tumino R et al (2014) Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort. Int J Cancer 134(1):92–101
36. Ko S, Kim B, Jo SS, Oh SY, Park JK (2007) Electrochemical detection of cardiac troponin I using a microchip with the surface-functionalized poly(dimethylsiloxane) channel. Biosens Bioelectron 23(1):51–59
37. Canbaz MC, Simsek CS, Sezginturk MK (2014) Electrochemical biosensor based on self-assembled monolayers modified with gold nanoparticles for detection of HER-3. Anal Chim Acta 814:31–38
38. Hervás M, López MA, Escarpa A (2012) Electrochemical immunosensing on board microfluidic chip platforms. TrAC, Trends Anal Chem 31:109–128
39. Zhi X, Liu QS, Zhang X, Zhang YX, Feng J, Cui DX (2012) Quick genotyping detection of HBV by giant magnetoresistive biochip combined with PCR and line probe assay. Lab Chip 12(4):741–745
40. Zhi X, Deng M, Yang H, Gao G, Wang K, Fu H et al (2014) A novel HBV genotypes detecting system combined with microfluidic chip, loop-mediated isothermal amplification and GMR sensors. Biosens Bioelectron 54:372–377
41. Nahavandi S, Baratchi S, Soffe R, Tang SY, Nahavandi S, Mitchell A et al (2014) Microfluidic platforms for biomarker analysis. Lab Chip 14(9):1496–1514
42. Morris MC, Depollier J, Mery J, Heitz F, Divita G (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19(12):1173–1176
43. Xu H, Aguilar ZP, Yang L, Kuang M, Duan H, Xiong Y et al (2011) Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials 32(36):9758–9765
44. Wu M, Mao C, Chen Q, Cu XW, Zhang WS (2010) Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls. Mol Biol Rep 37(1):339–343
45. Bange A, Halsall HB, Heineman WR (2005) Microfluidic immunosensor systems. Biosens Bioelectron 20(12):2488–2503
46. Jia X, Liu Z, Liu N, Ma Z (2014) A label-free immunosensor based on graphene nanocomposites for simultaneous multiplexed electrochemical determination of tumor markers. Biosens Bioelectron 53:160–166
47. Jiang W, Yuan R, Chai Y, Mao L, Su H (2011) A novel electrochemical immunoassay based on diazotization-coupled functionalized bioconjugates as trace labels for ultrasensitive detection of carcinoembryonic antigen. Biosens Bioelectron 26(5):2786–2790
48. Chen X, Jia X, Han J, Ma J, Ma Z (2013) Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites. Biosens Bioelectron 50:356–361
49. Tang D, Hou L, Niessner R, Xu M, Gao Z, Knopp D (2013) Multiplexed electrochemical immunoassay of biomarkers using metal sulfide quantum dot nanolabels and trifunctionalized magnetic beads. Biosens Bioelectron 46:37–43
50. Duraker N, Celik AN, Gencler N (2002) The prognostic significance of gastric juice CA 19–9 and CEA levels in gastric carcinoma patients. Eur J Surg Oncol 28(8):844–849
51. Suwa H, Ohshio G, Okada N, Wang Z, Fukumoto M, Imamura T et al (1997) Clinical significance of serum p53 antigen in patients with pancreatic carcinomas. Gut 40(5):647–653
52. Kishikawa H, Nishida J, Ichikawa H, Kaida S, Takarabe S, Matsukubo T et al (2011) Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status. Helicobacter 16(6):427–433